OMEGAQUANT ANALYTICS, LLC
Medtech · Private
blood test measuring erythrocyte omega-3 fatty acid levels as an early biomarker for Alzheimer's disease risk
- Grants
- $834K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $79K
- 2 awards · Defense
- #540 of 4531 in medtech
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Developing a blood fatty acid-based algorithm as an early predictor of insulin resistance: Applying machine learning to harmonized data from prospective cohort studies | $327,420 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing a blood fatty acid-based algorithm as an early predictor of cognitive decline and dementia: Applying machine learning to harmonized data from prospective cohort studies | $506,500 | |
| Federal contract | Department of Defense · Dbs Sample Cards For Vitamin D Collection And Analysis. | $48,180 | |
| Federal contract | Department of Defense · S2P2 : OMEGA-3 Lab Kit : Solicitation W911S225U1758 | $31,185 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 537 | ALLELE DIAGNOSTICS INC | $84K | — |
| 538 | Caption Health | $81K | $69M |
| 539 | Cleerly, Inc. | $80K | $266M |
| 540 | OMEGAQUANT ANALYTICS, LLC | $79K | — |
| 541 | ADM TRONICS UNLIMITED, INC. | $78K | $300K |
| 542 | STEXOLE LLC | $77K | — |
| 543 | Objective Biotechnology, Inc. | $75K | $715K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Method For Measuring And Managing Red Blood Cell OMEGA-3 Fatty Acid Docosahexaenoic Acid Level In Human Females To Support A Term Pregnancy And Reduce Risk Of Spontaneous Preterm Birthapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.